6-(Tetrahydro-2H-pyran-4-ylmethoxy)nicotinic Acid, 97.0%, 1g

BIS[2-((OXO)DIPHENYLPHOSPHINO)PHENYL]ETHER, 97%, 5g

3-(3,5-Dichlorophenyl)-1-methylimidazolidine-2,4-dione, 97%, 100mg

2-Fluoroisobutyric acid, 97.0%, 50g

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole, 95.0%, 25g

3-(1-methyl-1H-imidazol-2-yl)piperidine, 95.0%, 250mg

2-(Chloromethyl)-5-methoxypyridine, 95.0%, 1g

5,5-dimethylpiperazin-2-one, 95.0%, 100mg

4-CHLORO-1-TOSYL-1H-INDOLE, 95.0%, 500mg

spiro-[3.3]-Heptane-2,6-dicarboxylic acid, 95.0%, 5g

2,4-Dibromonicotinic acid, 97%, 1g

N-Benzyl-1,3-propanediamine>96.0%(GC)(T)5mL

Reference standard kit for MD100